Table 4.
Incidences of adverse events reported by >10% of patientsa
| Parameter | Patients Who Experienced at Least One AE
|
|
|---|---|---|
| MMF (n = 184) | IVC (n = 180) | |
| Deaths | 9 (4.9) | 5 (2.8) |
| Withdrawals as a result of AEs | 24 (13.0) | 13 (7.2) |
| All AEs | 177 (96.2) | 171 (95.0) |
| diarrhea | 52 (28.3) | 23 (12.8) |
| headache | 38 (20.7) | 47 (26.1) |
| peripheral edema | 35 (19.0) | 30 (16.7) |
| arthralgia | 29 (15.8) | 43 (23.9) |
| nausea | 27 (14.7) | 82 (45.6) |
| hypertension | 26 (14.1) | 25 (13.9) |
| nasopharyngitis | 25 (13.6) | 29 (16.1) |
| vomiting | 25 (13.6) | 68 (37.8) |
| cough | 24 (13.0) | 16 (8.9) |
| anemia | 23 (12.5) | 12 (6.7) |
| alopecia | 20 (10.9) | 64 (35.6) |
| abdominal pain | 19 (10.3) | 13 (7.2) |
| back pain | 19 (10.3) | 16 (8.9) |
| muscle spasms | 19 (10.3) | 17 (9.4) |
| rash | 19 (10.3) | 21 (11.7) |
| urinary tract infection | 19 (10.3) | 17 (9.4) |